Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Farxiga And Jardiance Have Two-Time Increased Risk For Amputations

November 23, 2018 By Law Offices of Thomas J. Lamb, P.A.

Patients using the diabetes drugs Farxiga and Jardiance had twice the risk for lower limb amputations relative to certain other diabetes medicines, according to a new observational study published in November 2018 by The BMJ medical journal in. However, in the US only a third diabetes drugs in the sodium-glucose cotransporter 2 (SGLT2) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Amputations, diabetes drugs, drug injury, Farxiga, Invokamet, Invokana, Jardiance

Fournier’s Gangrene: Side Effect For Invokana, Farxiga, And Jardiance

October 15, 2018 By Law Offices of Thomas J. Lamb, P.A.

From this August 29, 2018 Drug Safety Communication, “FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes”, we get the following details about this new safety issue for Invokana, Farxiga, Jardiance, and similar diabetes drugs: Fournier’s gangrene is an extremely rare but life-threatening … [Read more...]

Filed Under: Unsafe Drugs Tagged With: diabetes drugs, drug injury, drug side effects, Farxiga, Fournier’s Gangrene, Invokana, Jardiance

Increased Risks Of Lower-Limb Amputations For Farxiga And Jardiance

September 5, 2018 By Law Offices of Thomas J. Lamb, P.A.

During late August a presentation at the 2018 European Society of Cardiology Congress in Munich, Germany included evidence that the SGLT-2 inhibitors Invokana, Jardiance, and Farxiga all are associated with twofold increases for lower-limb amputations when compared to GLP-1 receptor agonists diabetes drugs. An August 25, 2018 Healio.com article, … [Read more...]

Filed Under: Uncategorized, Unsafe Drugs Tagged With: Amputations, diabetes drugs, drug injury, Farxiga, Invokana, Jardiance

Health Canada: OFEV Label Will Add Drug-Induced Liver Injury Warning

January 16, 2018 By Law Offices of Thomas J. Lamb, P.A.

On January 11, 2018 Health Canada issued a Dear Healthcare Professional Letter communication titled “OFEV (nintedanib) – Risk of Drug-Induced Liver Injury and the Need for Regular Monitoring of Liver Function”. From the Background Information section of that new Health Canada document we get this overview of the safety issue: OFEV (nintedanib) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug injury, drug side effects, drug-induced liver injury, OFEV

2017 Medical Articles: Association Of Melanoma With Viagra And Cialis

November 2, 2017 By Law Offices of Thomas J. Lamb, P.A.

The five brand name erectile dysfunction (ED) drugs in the phosphodiesterase 5 (PDE-5) inhibitors class are Viagra (sildenafil), Cialis (tadalafil), Levitra (vardenafil), Staxyn (vardenafil), and Stendra (avanafil). Cialis is also prescribed sometimes when doctors see the signs and symptoms of benign prostatic hyperplasia (BPH). Two other … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Adcirca, Cialis, drug injury, drug side effects, Levitra, Melanoma, melanoma skin cancer, Revatio, Staxyn, Stendra, Viagra

Keytruda / Opdivo / Yervoy: May Cause Vision Loss, Retinal Detachment

July 17, 2017 By Law Offices of Thomas J. Lamb, P.A.

A developing drug safety issue is presented in this news report, “FDA Considers Label Changes for Keytruda, Opdivo and Yervoy”, which was posted July 12, 2017 on the Regulatory Affairs Professional Society (RAPS) website. Here are some contextual details provided by reporter Zachary Brennan in this article: The consideration for changing the … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug injury, drug side effects, Keytruda, Opdiva, retinal detachment, vision loss, Yervoy

No Warning Added By FDA To Drug Label For Actemra About Pancreatitis

July 12, 2017 By Law Offices of Thomas J. Lamb, P.A.

An insightful article by reported Charles Piller, “Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients”, published June 5, 2017 online by STAT, put the spotlight on some serious but little-known side effects associated with this medicine from Genentech, Inc. From that recent article we get this rather … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Actemra, drug injury, drug side effects, Pancreatitis

New Anticoagulant BevyxXa Approved by the FDA

June 30, 2017 By Law Offices of Thomas J. Lamb, P.A.

On June 23, 2017, a new anticoagulant drug called BevyxXa (betrixaban) was approved by the FDA for the prevention of venous thromboembolism and pulmonary embolism. This drug acts as a direct Factor Xa inhibitor, similar to the other anticoagulant drugs Eliquis, Savaysa, and Xarelto. Unlike the anticoagulant Pradaxa, which is a direct … [Read more...]

Filed Under: Unsafe Drugs Tagged With: anticoagulants, betrixaban, bevyxxa, black-box drug label warning, bleeding risks, direct xa inhibitors, drug injury, drug injury lawsuits, drug side effects, Eliquis, FDA, NOACs, PE, Pradaxa, Pulmonary Embolism, Savaysa, venous thromboembolism, VTE, Xarelto

FDA Concern About Whether Victoza Is Associated With Pancreatic Cancer

June 26, 2017 By Law Offices of Thomas J. Lamb, P.A.

In advance of the June 20, 2017 FDA Advisory Committee meeting to discuss Novo Nordisk’s supplemental New Drug Application (sNDA) for approval of Victoza® (liraglutide) injection, we reviewed the FDA Briefing Document for this Endocrinologic and Metabolic Drugs Advisory Committee Meeting (EMDAC), which includes a section titled “ONCOLOGY CONSULT: … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug injury, drug side effects, Pancreatic Cancer, Victoza

Ocrevus Patient Gets Progressive Multifocal Leukoencephalopathy (PML)

June 1, 2017 By Law Offices of Thomas J. Lamb, P.A.

A May 24, 2017 Reuters news report, “Deadly brain infection in German MS patient prompts Roche investigation”, brings some unwanted attention to a potential drug safety issue for Ocrevus (ocrelizumab injection) which may negatively affect this projected sales success. From this recent Reuters article: A person in Germany treated with Roche Holding … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug injury, drug side effects, Ocrevus, Progressive Multifocal Leukoencephalopathy (PML)

  • 1
  • 2
  • 3
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.